Cargando…
Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
Abundant evidence proves the therapeutic effect of adipose-derived mesenchymal stem cells (ADMSCs) in the treatment of diabetes mellitus. However, the problems have not been solved that viability of ADMSCs were inconsistent and the cells quickly undergo senescence after in vitro cell culture. In add...
Autores principales: | Li, Balun, Cheng, Xuedi, Aierken, Aili, Du, Jiaxin, He, Wenlai, Zhang, Mengfei, Tan, Ning, Kou, Zheng, Peng, Sha, Jia, Wenwen, Tang, Haiyang, Hua, Jinlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554153/ https://www.ncbi.nlm.nih.gov/pubmed/34722505 http://dx.doi.org/10.3389/fcell.2021.722365 |
Ejemplares similares
-
Corrigendum: Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
por: Li, Balun, et al.
Publicado: (2021) -
Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway
por: Aierken, Aili, et al.
Publicado: (2022) -
Mesenchymal Stem Cells Pretreated with Collagen Promote Skin Wound-Healing
por: Kou, Zheng, et al.
Publicado: (2023) -
Effect of Melatonin for Regulating Mesenchymal Stromal Cells and Derived Extracellular Vesicles
por: Feng, Zi-Yi, et al.
Publicado: (2021) -
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020)